Corporate Finance

Assignment

PFIZER LTD

Company Code - PFIZER

By – Prakhar Singh (19PGP101)

Executive summary

• Pfizer Limited
manufactures, markets,
trades in, and exports
pharmaceutical products
in India and
internationally.
Share price

• Stable Share Price: 500680 has not had significant price

volatility in the past 3 months.
Market Performance
 • Below Fair Value: 500680 (₹4188.7) is trading above our estimate of fair
Valuation value (₹358.28)
• Significantly Below Fair Value: 500680 is trading above our estimate of fair
value.
•
Price to Earnings
Ratio
Future Growth
• 24.7% Forecasted Pharmaceuticals & Biotech industry annual growth
in earnings
• Pfizer has not provided enough past data and has no analyst forecast,
its future earnings cannot be reliably calculated by extrapolating past
data or using analyst predictions.
Return On Equity
 • Short Term Liabilities: 500680's short term assets (₹27.8B) exceed its short
term liabilities (₹9.0B).
Financial Position
• Long Term Liabilities: 500680's short term assets (₹27.8B) exceed its long term
Analysis liabilities (₹692.5M).
•
Debt To Equity History and Analysis
• Debt Level: 500680's debt to equity ratio (0.08%) is
considered satisfactory.
• Reducing Debt: Insufficient data to determine if 500680's debt to
equity ratio has reduced over the past 5 years.
• Debt Coverage: 500680's debt is well covered by operating cash
flow (6862.4%).
• Interest Coverage: 500680 earns more interest than it pays, so
coverage of interest payments is not a concern.
Balance Sheet